DSW Capital (DSW) Competitors GBX 62.90 +2.90 (+4.83%) As of 07/25/2025 11:18 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsInsider TradesBuy This Stock DSW vs. GRA, CTG, VNET, MIND, REAT, CPP, RBGP, REL, RTO, and ITRKShould you be buying DSW Capital stock or one of its competitors? The main competitors of DSW Capital include Grafenia (GRA), Christie Group (CTG), Vianet Group (VNET), Mind Gym (MIND), REACT Group (REAT), CPPGroup (CPP), RBG (RBGP), Relx (REL), Rentokil Initial (RTO), and Intertek Group (ITRK). These companies are all part of the "specialty business services" industry. DSW Capital vs. Its Competitors Grafenia Christie Group Vianet Group Mind Gym REACT Group CPPGroup RBG Relx Rentokil Initial Intertek Group Grafenia (LON:GRA) and DSW Capital (LON:DSW) are both small-cap industrials companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends, media sentiment and valuation. Do insiders & institutionals hold more shares of GRA or DSW? 43.6% of Grafenia shares are held by institutional investors. Comparatively, 6.7% of DSW Capital shares are held by institutional investors. 44.9% of Grafenia shares are held by company insiders. Comparatively, 75.5% of DSW Capital shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more risk and volatility, GRA or DSW? Grafenia has a beta of 0.33, meaning that its stock price is 67% less volatile than the S&P 500. Comparatively, DSW Capital has a beta of 0.22, meaning that its stock price is 78% less volatile than the S&P 500. Is GRA or DSW more profitable? DSW Capital has a net margin of 3.63% compared to Grafenia's net margin of -11.78%. DSW Capital's return on equity of 1.10% beat Grafenia's return on equity.Company Net Margins Return on Equity Return on Assets Grafenia-11.78% -82.44% -4.07% DSW Capital 3.63%1.10%-0.38% Which has stronger earnings & valuation, GRA or DSW? DSW Capital has lower revenue, but higher earnings than Grafenia. Grafenia is trading at a lower price-to-earnings ratio than DSW Capital, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGrafenia£11.68M0.00-£1.41M-£0.01N/ADSW Capital£2.67M5.97£97.05K£0.38165.50 Does the media prefer GRA or DSW? In the previous week, DSW Capital's average media sentiment score of 0.00 beat Grafenia's score of -1.20 indicating that DSW Capital is being referred to more favorably in the news media. Company Overall Sentiment Grafenia Negative DSW Capital Neutral SummaryDSW Capital beats Grafenia on 8 of the 11 factors compared between the two stocks. Get DSW Capital News Delivered to You Automatically Sign up to receive the latest news and ratings for DSW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DSW vs. The Competition Export to ExcelMetricDSW CapitalSpecialty Business Services IndustryIndustrials SectorLON ExchangeMarket Cap£15.93M£6.86B£7.76B£3.02BDividend Yield2.78%4.93%4.55%5.02%P/E Ratio165.5033.3925.71160.65Price / Sales5.97140.09101.63278,114.27Price / Cash5.6840.5427.2027.97Price / Book1.827.804.474.70Net Income£97.05K£144.67M£795.63M£5.90B7 Day Performance1.45%0.40%1.47%0.00%1 Month Performance10.35%0.29%5.16%7.23%1 Year Performance4.83%41.81%30.66%70.70% DSW Capital Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DSWDSW CapitalN/AGBX 62.90+4.8%N/A+4.8%£15.93M£2.67M165.5015Gap UpGRAGrafeniaN/AN/AN/AN/A£41.93M£11.68M-1,075.0092Negative NewsGap UpCTGChristie GroupN/AGBX 114+3.6%N/A-7.0%£30.24M£68.04M-876.923,450Gap DownVNETVianet GroupN/AGBX 92.75-2.4%N/A-31.6%£27.00M£14.99M34.123,220Gap UpHigh Trading VolumeMINDMind GymN/AGBX 17.50flatN/A-32.7%£17.54M£44.98M-1.61270REATREACT GroupN/AGBX 50.20-3.5%N/A-35.1%£11.87M£20.94M52.93301CPPCPPGroupN/AGBX 129+6.2%N/A-0.9%£11.56M£191.04M-2.744,558Gap UpRBGPRBGN/AN/AN/AN/A£1.15M£40.93M-0.05183RELRelx1.7376 of 5 starsGBX 3,880-1.0%GBX 4,770+22.9%+9.1%£71.75B£9.09B38.7335,700Trending NewsEarnings ReportAnalyst ForecastRTORentokil Initial4.3252 of 5 starsGBX 363.50+2.2%GBX 478.33+31.6%-20.7%£9.11B£5.38B23.3262,931ITRKIntertek Group1.9574 of 5 starsGBX 4,841.14-0.8%GBX 5,400+11.5%-2.1%£7.77B£3.34B25.2343,908 Related Companies and Tools Related Companies Grafenia Alternatives Christie Group Alternatives Vianet Group Alternatives Mind Gym Alternatives REACT Group Alternatives CPPGroup Alternatives RBG Alternatives Relx Alternatives Rentokil Initial Alternatives Intertek Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:DSW) was last updated on 7/28/2025 by MarketBeat.com Staff From Our PartnersAI Frenzy Could Send ‘EarnPhone’ SoaringThe hidden fuel behind AI? Your phone. Billions of data points — from your clicks, swipes, scrolls, and sea...Mode Mobile | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredNvidia’s next AI move could catch traders flat-footedTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredA grave, grave error.Nvidia just hit $4 trillion… but a tech apocalypse may already be underway. A controversial new documentary...Porter & Company | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIt’s my duty to share the “truth” I see behind this bible verseFormer CIA advisor Jim Rickards believes President Trump has just unlocked what the Bible foretold — a $150 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DSW Capital plc Please log in to your account or sign up in order to add this asset to your watchlist. Share DSW Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
